SCHEMBL7364660

SCHEMBL7364660

OCCC[CH]c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
CYP2A6 P11509 1/20 0.40
TDP1 Q9NUW8 1/20 0.37
TSHR P16473 2/20 0.35
MAOB P27338 1/20 0.35
PAM P19021 1/20 0.34
TBXAS1 P24557 1/20 0.34
RECQL P46063 2/20 0.33
LMNA P02545 2/20 0.33
KMT2A Q03164 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.33
HDAC3 O15379 1/20 0.33
TNKS O95271 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HCAR2 Q8TDS4 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9170505 0.91 TBXAS1 (0.42) ALDH1A1CYP2A6TDP1TSHRMAOB
SCHEMBL325675 0.85 ALDH1A1 (0.43) ALDH1A1CYP2A6TDP1TSHRMAOB
SCHEMBL8154332 0.85 ALDH1A1 (0.48) ALDH1A1CYP2A6TDP1TSHRMAOB
SCHEMBL8947076 0.80 HDAC2 (0.39) TSHRTBXAS1LMNAHDAC3HDAC4
SCHEMBL15323034 0.77 HSD11B1 (0.38) ALDH1A1TSHRRECQLLMNAKMT2A
SCHEMBL8936182 0.77 HSD17B10 (0.44) CYP2A6MAOBLMNAL3MBTL1CYP1A2
SCHEMBL5470592 0.77 PAM (0.50) MAOBPAMTBXAS1HDAC3HDAC4
SCHEMBL5470587 0.77 PAM (0.50) MAOBPAMTBXAS1HDAC3HDAC4
SCHEMBL7453030 0.76 ALDH1A1 (0.40) ALDH1A1CYP2A6TDP1TSHRMAOB
SCHEMBL1449119 0.76 ALDH1A1 (0.46) ALDH1A1CYP2A6TSHRMAOBPAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815108-A1 CYCLIC UREA HIV PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-01-07 EP claimed
WO-1996029329-A1 CYCLIC UREA HIV PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-09-26 WO claimed
US-9074021-B2 Cellulose derivative, thermo-molding material, molded body and method for preparation thereof, and case for electric and electronic devices FUJIFILM CORPORATION (JP) 2015-07-07 US disclosed
EP-2465899-B1 CELLULOSE DERIVATIVE, THERMOFORMED MATERIAL, MOLDED BODY, PRODUCTION METHOD THEREFOR, AND CASING FOR ELECTRICAL AND ELECTRONIC EQUIPMENT FUJIFILM CORP (JP) 2014-11-05 EP disclosed
US-20120165517-A1 CELLULOSE DERIVATIVE, THERMO-MOLDING MATERIAL, MOLDED BODY AND METHOD FOR PREPARATION THEREOF, AND CASE FOR ELECTRIC AND ELECTRONIC DEVICES FUJIFILM CORPORATION (JP) 2012-06-28 US disclosed
EP-2465899-A1 CELLULOSE DERIVATIVE, THERMOFORMED MATERIAL, MOLDED BODY, PRODUCTION METHOD THEREFOR, AND CASING FOR ELECTRICAL AND ELECTRONIC EQUIPMENT FUJIFILM Corporation (JP) 2012-06-20 EP disclosed
EP-0815108-A1 CYCLIC UREA HIV PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-01-07 EP disclosed
WO-1996029329-A1 CYCLIC UREA HIV PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-09-26 WO disclosed
US-4831041-A ANTIULCER AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-05-16 US disclosed
EP-0268989-A1 Imidazopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-06-01 EP disclosed